SUMAGIC Plant Growth Regulator

SECTION 2: Hazards identification

EMERGENCY OVERVIEW CAUTION • Causes eye irritation. • Avoid contact with eyes, skin and clothing. • Keep out of reach of children.

Potential health effects

Acute Toxicity (Primary Routes of Exposure) Signs and Symptoms of Systemic Effects: Signs of toxicity observed in animals at high dose levels of Uniconazole-P include decreased activity, poor coordination, irregular respiration and liver toxicity. Acute Eye Contact: This product can cause brief and/or minor eye irritation. The expected adverse health effects resulting from an exposure may include redness and possible swelling. Acute Skin Contact: This product can cause brief and/or minor irritation. The expected adverse health effects resulting from an exposure may include redness and possibly some minor swelling. This product is minimally toxic when absorbed through the skin. This product is not expected to cause allergic skin reactions. Acute Ingestion: This product is minimally toxic when ingested. Acute Inhalation: This product is minimally toxic when inhaled. Chronic Toxicity (including cancer): Uniconazole-P produced liver tumors in mice but is not considered a human carcinogen. Anemia and changes in the liver were the primary effects observed at high dose levels in animals. Developmental Toxicity (birth defects): Uniconazole-P produced effects on the developing fetus only at doses that were also toxic to the pregnant female. Reproductive Toxicity: Uniconazole-P Technical did not produce reproductive toxicity in animals. Potentially Aggravated Medical Conditions: Individuals with preexisting diseases of the liver or kidney may have increased susceptibility to the toxicity of excessive exposures. For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Regulatory Information, refer to Section 15.